420 with CNW – Poll Shows Americans want CBD as an OTC Drug

A survey conducted by Gallup has found that the majority of Americans who are familiar with CBD (cannabidiol) want it available as an over-the-counter drug. The results of the survey were released on Friday last week (June 14).

The CBD craze traces its roots to the cannabis reform movement, and it gained momentum when the Farm Bill 2018 became law last year. This bill legalized industrial hemp and all its derivatives, including CBD.

The survey involving 1,017 participants was conducted over the phone in a bid to get insights into the widespread appeal of CBD. The interviews were conducted from May 15-30.

In all, 39 percent of the people polled revealed that they want to see CBD available as an OTC drug while 21 percent said CBD should be accessed using a doctor’s prescription. 36 percent of the people polled revealed that they weren’t familiar with this particular compound of hemp and marijuana plants.

When Gallup focused on those who were familiar with CBD and asked them whether CBD should be purchased as an OTC drug or as a prescription drug, 61 percent favored the OTC option while 33 percent preferred to see it as a prescription drug.

The participants in the poll were also asked to rate how familiar they were with CBD. 14 percent looked at themselves as “very familiar” with it, 33 percent felt they were “somewhat familiar”, 17 percent felt they were “not too familiar” while 36 percent confessed that they “weren’t familiar at all” with cannabidiol.

Gallup again narrowed its attention to only those who categorized themselves as very familiar with cannabidiol and asked them for their opinion about the medicinal value of CBD. 90 percent of this group believed that CBD had therapeutic benefits.

Of those who thought CBD had medicinal benefits, 33 percent said it had “a lot of benefits”, 45 percent felt CBD had “some benefits” and 14 percent thought cannabidiol had “a few benefits.” 3 percent were neutral on the matter while 4 percent said cannabidiol didn’t have any medical benefits.

Commenting about their findings, Gallup wrote that most Americans already believe that CBD has medicinal value even if research has been slow in proving or disproving many of the therapeutic benefits attributed to CBD. Gallup is convinced that the fraction of people who think CBD is medicinal is most likely to grow as more people get exposed to this non-psychoactive compound.

This possibility takes on a greater degree of certainty given that the FDA has already been convinced enough of CBD’s therapeutic benefits to the extent of approving a drug targeting rare forms of epilepsy.

The pressure on federal agencies like the FDA and Congress to pass laws legalizing CBD as a food supplement and other uses is therefore going to increase as the months go by.

Cannabis industry analysts are of the opinion that the Gallup findings didn’t catch industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) by surprise.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Congress to Consider Several Cannabis Amendments this Week

The House Rules Committee of Congress is set to hear almost a dozen amendments related to marijuana this week. This crucial committee will decide which of those amendments are cleared for a vote by the whole House. The amendments are being considered this week because those that pass will form part of the appropriations bill for funding sections of the federal government in the next fiscal year.

Rep. Tom McClintock (R-CA) and Earl Blumenauer (D-OR) have reintroduced an amendment intended to prevent the Department of Justice from using its budget to get in the way of states which have enacted their own marijuana laws. An existing spending rider only covers medical marijuana, but the proposed amendment takes this further and seeks to protect state-level recreational marijuana as well. This new amendment is similar to another which failed by just nine votes in 2015.

Another amendment before the committee was introduced by Rep. Stacy Plaskett (D-VI). This measure is intended to correct the inadvertent omission of the U.S. Virgin Islands from the list of states and territories whose medical marijuana programs are protected from Justice Department interference by a spending rider.

Rep. Blumenauer didn’t stop at the amendment he co-authored with McClintock. He also brought several other amendments on his own. One amendment seeks to bar the Department of Justice from interfering in the tribal medical marijuana programs even if the states in which those tribal communities are found haven’t enacted medical cannabis laws. Three other amendments filed by the legislator also protect tribal marijuana programs in various ways.

Two other amendments by Blumenauer touch on the Department of Veteran Affairs. One protects VA workers from being penalized for filing paperwork in compliance with state laws regarding medical marijuana. Another aims at protecting VA doctors from being penalized for any marijuana-related work they do in states where medical marijuana is legal.

The Rules Committee will also consider a measure tabled by Rep. Ocasio-Cortez (D-NY) seeking to divert $30 million from the funding allocated to the DEA. This money should go towards the Comprehensive Opioid Abuse Program. In this way, the DEA will fall in line with the current thinking that drug addiction is a public health concern rather than a crime.

Rep. Jerry McNerney (D-CA) has also tabled an amendment containing a spending proposal for the FDA to undertake a process through which CBD (cannabidiol) will become legal as an additive in food supplements and conventional foods.

It is interesting to note that many of the amendments seem to be geared at introducing marijuana policy reforms using the appropriations process. The success of the spending rider placed on the DOJ years ago appears to have provided an example that advocates want to use to initiate incremental changes to the existing marijuana policies.

Analysts wonder what major cannabis industry entities like Net Element Inc. (NASDAQ: NETE) and Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) think about this change in strategy.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Acquisitions Reveal the Steadily Changing Shape of the Cannabis Sector

CannabisNewsWire Editorial Coverage: The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has taken a similar path with the acquisition of Newstrike. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is building a positive public profile through releasing educational tools. Aphria Inc. (TSX: APHA) (NYSE: APHA) has expanded the hunt for cultivation licenses to Germany. Meanwhile, companies such as Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) keep releasing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Maine Relaxes Residency Requirements for Recreational Marijuana Companies

The Veterans and Legal Affairs Committee of Maine’s Assembly has voted 7-2 approving the draft rules for the legalization of recreational marijuana in the state. The approved rules relax the residency requirements included with the purpose of keeping out-of-state companies from moving in and controlling the recreational market at the expense of local companies.

The committee removed language that limited out-of-state players from having majority stake in recreational marijuana companies which operate within Maine. In its place, the committee left a provision to the effect that Mainers who have resided in the state for at least four years will have 51 percent ownership of any company to be licensed to conduct business in the recreational marijuana arena. This means that the local ownership can be several individuals or entities as long as their combined stake adds up to 51 percent in the company.

Erik Gundersen, the head of the Office of Marijuana Policy, said his office wants to see the tools which will make it possible for the letter and the spirit of the law to be implemented. He added that the law should be made by Mainers, within Maine and for the benefit of Mainers.

The Maine Office of Marijuana Policy was instrumental in including language which specifically sought to lock out large corporations from using out-of-state management contracts to dominate the local recreational cannabis market in the fashion of what is happening in Massachusetts and even in the medical marijuana program of Maine.

However, not everyone was thrilled with that proposal to lock out out-of-state companies. Some people said that the provision would be counterproductive because it would hurt the interests of Mainers in the long run since the capital and technical expertise of out-of-state operators was needed to kick-start the recreational marijuana industry. They cited the example of manufacturing equipment which costs millions and would be out of reach for most local investors.

Wellness Connection of Maine, the biggest medical marijuana company in the state, had even threatened to sue the regulator if the original text of the bill was retained in the final language of the law. The company felt that the provision about out-of-state companies was targeting it since it has complex management contracts with out-of-state operators.

The time at which marijuana companies should close their doors also generated a lot of debate in the committee. The original bill stipulated that retail outlets should close at 9pm, but this was changed to 10pm to avoid sending people to black market players. Law enforcement agencies had pushed for the 9pm closing time.

The committee decided that local authorities shouldn’t have the right to set their own operating hours for cannabis businesses. However, cannabis businesses could apply to open for extended hours and the regulator would consider their request on a case-by-case basis.

Now that the bill has been cleared by the committee, advocates hope that the entire House will vote on it before the legislative session ends on June 19.

Marijuana industry analysts hope that the cannabis industry, including players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and VPR Brands LP (OTC: VPRB), will be happy that a robust debate was conducted and the strongest arguments won the day during the committee session.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New York Legislators Could Vote on Cannabis Legalization This Week

As the countdown to the end of this legislative session in New York State enters the final stages, plans to legalize recreational marijuana have been revived with the possibility of a vote on the matter this week.

While momentum to get recreational weed legal appeared to fade once lawmakers in New Jersey announced that they were giving up on trying to use legislative means to end prohibition, advocates in the Empire State are brimming with optimism that lawmakers may have reached a deal and the bill will pass.

Democrats in both the Assembly and Senate held conferences last week in a bid to discuss the fine print of the legislation. Sources close to those who attended these meetings reported that the conferences went well and that the bill may have enough support to sail through.

On Saturday last week, the staff of the legislative leaders in Senate and the Assembly met those from Gov. Cuomo’s office to talk about the final language of the bill which will be put before lawmakers within the last days of the legislative session.

Earlier on Wednesday last week, the senate version of the legalization bill was given the “same as” status indicating that its language was identical to the language of the version in the Assembly. This is an indicator that both chambers agreed on the wording of the bill, and that is an early indicator of possible success when a vote is called.

The speaker of the Assembly, Carl Heastie (D), revealed on Friday that the Democrats hadn’t yet decided on whether to bring the matter to the floor of the House but added that the bill had support among the Democratic members of the chamber. Despite the optimism, analysts think that the bill is still short by two votes in the state Senate.

Sensing that the bill may soon be up for a vote, key state officials have been urging legislators and the governor to include a given list of provisions in the final text of the bill.

Letitia James (D), the State Attorney General wrote that the bill should include provisions to expunge all previous convictions for non-violent marijuana crimes.

NYC Mayor Bill de Blasio (D) also pushed for expungement and added that the bill legalizing recreational marijuana should aim at empowering local businesses rather than big corporations.

The district attorneys of Albany County and Manhattan jointly wrote an op-ed urging lawmakers to end what they called “staggering inequities” and also promote public safety by enacting the bill to legalize recreational marijuana.

The legislative session will end on Wednesday, so lawmakers have a narrow window within which to schedule a vote in both chambers.

Industry watchers have been wondering whether marijuana industry players like SinglePoint Inc. (OTCQB: SING) and Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FRA: O3X4) experience as much tension when a major decision is due as what the people of New York State are experiencing in these final days of the legislative session.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Searching for the Next Super Nova

CannabisNewsWire Editorial Coverage: Skepticism has been squashed and all apprehension eliminated. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?

Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Last October Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) soared 60% in one week when the company announced a deal to buy PharmCann. Florida-based Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL) went public last September through a reverse merger in Canada and soared 200% after a strong 2018 Q2. Already up big on Canadian exchanges, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) became the first pure-play marijuana stock to list on NASDAQ around $7 and just bounced off $23 a share. Last year, Tilray Inc. (NASDAQ: TLRY) became the first cannabis company to…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Mississippi Medical Cannabis Ballot Measure Close to Attaining Signature Target

Activists in Mississippi have revealed that they are about to reach the required number of voter signatures in order to see an initiative about medical marijuana included on the ballot in 2020.

Once the organizers submit that list of signatures, the Secretary of State will go through it and certify that each of the signatures belongs to a valid voter in the state. The organizers have emphasized that they will not stop once they reach the minimum number of signatures required. Instead, they will keep gathering more until the submission deadline in September is reached. The extra signatures will serve as an insurance policy just in case some of the signatures collected are deemed invalid. So far, about two-thirds of the required number of signatures have already been collected.

State law requires that if the petition is to be included on the ballot, it must be supported by at least 86,185 registered voters across the state. Additionally, the law also sets minimum numbers of signatures that have to be collected from each of the Congressional Districts in Mississippi.

The initiative for which signatures are being collected seeks to create a law under which patients suffering from debilitating conditions can consult their doctors and obtain a recommendation to use medical marijuana.

22 qualifying conditions, including PTSD, cancer, chronic pain and epilepsy have been suggested as conditions for which patients can use medical marijuana. Patients who get recommendations from their doctors and are registered by the state will be eligible to buy a maximum of 2.5 ounces of medical cannabis within a two-week window.

Currently, the state only allows a limited number of patient categories to use CBD oil to manage their health conditions. This oil has to be purchased from a few highly regulated suppliers whose products have been subjected to rigorous testing at the National Center for Natural Products Research.

The NCNPR is based at the University of Mississippi where the only federally approved manufacturing facility for research-grade cannabis is based.

If the medical marijuana initiative makes it onto the ballot and gets the approval of voters, the Department of Health will be responsible for establishing and regulating a more robust system through which patients can access medical marijuana.

The steps taken to get medical marijuana on the ballot in Mississippi follow the regional trend which has seen several states make marijuana law reforms. Texas has decriminalized marijuana possession and passed a bill to expand its medical cannabis program. Similarly, Alabama’s legislature recently passed a bill to legalize medical marijuana while Georgia also expanded its medical marijuana program.

According to analysts, the positive changes in this region of the U.S. could signal to industry players like MustGrow Biologics Corp. and Marijuana Company of America Inc. (OTCQB: MCOA) that the entire country may soon embrace marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Group Claims Federal Government Broke the Law in Cannabis Scheduling Evaluation

The Competitive Enterprises Institute, a libertarian think tank, has claimed in a formal filing that the federal government erred in the way it handled the scientific evaluation of cannabis’ therapeutic value, and the government must therefore take steps to fix the errors it made.

Their request for correction was sent to the Department of Health and Human Services (U.S. HHS). HHS had written to the DEA in 2015 and the DEA relied on that letter from HHS in determining that marijuana be classified as a Schedule 1 drug in the U.S.

According to CEI (Competitive Enterprises Institute), the letter sent by HHS lacked a very important element which is required by federal law. The federal Information Quality Act demands that such “highly influential scientific assessment” as the contents of the HHS letter to the DEA be subjected to a peer review evaluation before the information therein can be relied upon when making regulatory decisions.

No such peer review was conducted, and the CEI is demanding that HHS withdraws its letter to the Drug Enforcement Administration until the requisite peer review exercise has been done as stipulated in the law.

The DEA leaned heavily on the contents of the letter written by HHS to the effect that “marijuana has no recognized medical use in the U.S., has a high potential for abuse and doesn’t have an acceptable level of safety even when used under medical supervision.” Based on this information, the DEA rejected an application which had been made to have marijuana rescheduled in 2016.

In its letter to HHS, CEI points out that various medical associations and a huge fraction of the public in the U.S. have formed a largely different conclusion about marijuana. By law, HHS now has a maximum of 120 days within which to respond to the concerns raised by the Competitive Enterprises Institute.

Devin Watkins, an attorney for CEI, says that the federal government’s policy is likely to change if a reassessment of the matter is conducted. This is especially likely given that 33 states across the country have legalized marijuana for medical use.

The attorney added that the reassessment would be significant in ensuring that government agencies don’t brand uninformed opinions as scientific positions upon which public policies are made. Independent experts can shine a torch on the opinion of an agency and correct it if a mistake has been made.

Industry observers suspect that the entire cannabis industry, including players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Hemptown USA, are likely to follow keenly how HHS responds to the letter written by CEI.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Nevada Bans Employers from Denying Jobs to Applicants Who Test Positive for Cannabis

From the first day of 2020, no employer in Nevada will be allowed to deny a job applicant employment just because that individual tested positive for marijuana during a pre-employment drugs test. The ban is contained in a bill which was signed into law by Gov. Sisolak on June 5. This makes Nevada the first state to enact such legislation in the country.

The new law contains some exceptions for people who may be denied employment on the basis of pre-employment marijuana screening. These include firefighters, EMTs, those who operate vehicles, federal government employees and anyone else applying for a job that the employer deems to be safety-sensitive.

The law also states that when an employer requires a prospective hire to be tested for marijuana, that potential employee has the right to have another test done within 30 days and the employer is bound to accept the results of that additional test. This extra test is at the expense of the prospective employee, according to the newly signed law.

Gov. Sisolak said that he was happy to sign AB132 because the cannabis industry in Nevada was growing and there was need to pass appropriate laws so that all residents of the state remain eligible to take advantage of all the opportunities available. He added that the exceptions included in that law are a matter of commonsense since matters of public safety and transportation have to be taken seriously.

This law has been regarded as long overdue by cannabis advocates since it was naturally expected that positive test results during pre-employment drugs screening would increase after the state legalized recreational marijuana in 2016 and commercial sales started a year later for adults 21 and older.

The law passed and enacted in Nevada is similar to the bill which was passed by the New York City Council in April this year. That bill banned employers from demanding that job applicants pass a drugs test for marijuana as a condition for being employed.

In Maine where recreational marijuana is legal, state law bans employers from discriminating people based on whether they use or don’t use marijuana. However, there is no specific provision banning marijuana testing during the employee hiring process.

Now that Nevada has paved the way, many other states are likely to ask themselves why they hadn’t thought of passing such a law since it is only logical that once recreational marijuana is legal, adults will legally use it and it would be unfair to deny them jobs because they used a legal substance.

Industry commentators would be glad to hear what different companies in the cannabis industry, such as Green Hygienics Holdings Inc. (OTCQB: GRYN) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), have to say about the developments in the cannabis industry in Nevada.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Colorado Hits the $1 Billion Cannabis State Revenue Mark

The state of Colorado has now pocketed more than $1 billion in revenue from the legal cannabis industry. This marks yet another milestone for the state which legalized marijuana in 2014.

According to marijuana sales data which has just been released by the state, cannabis sales hit the $6.5 billion mark at the end of May this year. The data also shows that the sales of recreational marijuana are continuing to rise higher as the months roll by.

April and May 2019 have also been the best months so far in the entire history of the cannabis industry in Colorado with the monthly state revenue reaching the highest level ever at $24.2 million in April. The state took approximately three and a half years to reach cannabis sales totaling $500 million, but the state was able to double that figure in less than two years to cross the $1 billion mark.

Since July 2017, the revenue collected by the state from the cannabis industry has never gone below $20 million each month. This shows massive growth given that the total state revenue from marijuana in February 2014 was just $3.5 million.

Speaking at a Net Net event in Denver on May 1, Gov. Polis revealed that the marijuana industry was doing very well because it had created “tens of thousands of jobs, reducing crime, filling up buildings and bringing state revenue.”

Speaking of creating jobs, there are 41,076 people who have licenses to work in the Colorado cannabis industry. It is reasonable to conclude that nearly all those people are indeed employed in the industry since the licenses are renewed every two years and it wouldn’t make sense for someone to pay for and renew a license if they aren’t working in the industry.

Gov. Polis wants to see the cannabis industry take even bigger strides and take full advantage of its trailblazer status across the country. He knows that cannabis sales will never equal those in bigger states, such as New Jersey and California, so he has set his sights on other ways through which Colorado can remain a leader in the industry. For example, he wants to see cannabis point of sale systems, cannabis genetics and cannabis chemistry innovations headquartered in Colorado from where other states are served by those companies.

With sales and state revenues hitting such highs, who would blame the governor for dreaming big? The situation in Colorado is far different from other states, such as California, where the legal cannabis industry is struggling under the yoke of high taxes, a vibrant black market and legal battles with local authorities and cities which have banned marijuana sales in their jurisdictions.

If only one could be a fly on the wall and hear what goes on in the corridors of companies like Golden Developing Solutions Inc. (OTC: DVLP) and Geyser Brands Inc. (TSX.V: GYSR) as they talk about the contrast between what is happening in Colorado and in California!

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com